SCHEMBL4263446

SCHEMBL4263446

COc1ccc(C=Cc2ccc3c(c2)NC(=O)CO3)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
ALDH1A1 P00352 4/20 0.59
KDM4E B2RXH2 3/20 0.59
NR3C2 P08235 2/20 0.58
LMNA P02545 2/20 0.58
KMT2A Q03164 2/20 0.55
POLB P06746 1/20 0.55
HPGD P15428 1/20 0.55
DRD4 P21917 4/20 0.54
DRD2 P14416 3/20 0.54
MMP12 P39900 1/20 0.54
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PARP1 P09874 1/20 0.50
DRD3 P35462 2/20 0.49
BRD4 O60885 2/20 0.48
CREBBP Q92793 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13932043 1.00 MAPT (0.59) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL13932053 0.92 MAPT (0.57) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL4271342 0.92 MAPT (0.57) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL13932125 0.86 NR3C2 (0.55) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL4266687 0.86 NR3C2 (0.55) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL705600 0.84 MAPT (0.64) MAPTALDH1A1KDM4ELMNAKMT2A
SCHEMBL13932091 0.84 NR3C2 (0.58) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL4259476 0.84 NR3C2 (0.58) MAPTALDH1A1KDM4ENR3C2LMNA
SCHEMBL13932080 0.83 ALDH1A1 (0.67) MAPTALDH1A1NR3C2LMNAKMT2A
SCHEMBL4267374 0.83 ALDH1A1 (0.67) MAPTALDH1A1NR3C2LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US claimed
JP-2008508314-A 2008-03-21 JP claimed
EP-1778242-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2007-05-02 EP claimed
WO-2006015259-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2006-02-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS NR5A1, ESRRA, NR3C1 MAPT 3273/4885ALDH1A1 3483/4885KDM4E 2686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.